Type of Submission

Poster

Keywords

Probiotics, efficacy, Irritable Bowel Syndrome, treatment, management, therapeutic, effective

Abstract

Aim: Probiotics are an attractive therapy for patients dealing with irritable bowel syndrome (IBS) in light of decreased financial costs, fewer medications, and a more natural approach. In this review of literature our purpose was to answer the following PICO question: “In adults with IBS, how does supplemental probiotic use compared to no probiotic use affect IBS symptoms?” Methods: In our review of the literature, the databases searched were CINAHL, MEDLINE, Cochrane, PubMed, Google Scholar, and Onesearch from the years 2008-2018; from which we found ten articles published within the last six years. Results: Seventy percent of the articles reviewed for our research identified that both the experimental (probiotic) and control (placebo) groups showed equal significant improvement in the management of IBS symptoms. Sixty percent of our articles studying multispecies versus monospecies probiotic therapy observed a greater therapeutic response when using probiotics in combination rather than individually. Lastly, 60% observed a therapeutic response in the reduction of IBS symptoms. Conclusion: The results of our review indicated that there was significant evidence for the use of probiotics in alleviating symptoms of IBS. However, the benefit of probiotics was equal to that of the placebo or not significantly greater. Therefore, we concluded that a pilot of change in practice should be considered, but there is still a need for further investigation on this topic. Keywords: Probiotics, Efficacy, Irritable Bowel Syndrome, Treatment, Management, Therapeutic, Effective.

Campus Venue

Stevens Student Center Lobby

Location

Cedarville, OH

Start Date

4-3-2019 11:00 AM

End Date

4-3-2019 2:00 PM

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS
 
Apr 3rd, 11:00 AM Apr 3rd, 2:00 PM

Probiotic Use and Their Effect on IBS Symptoms: A Review of Literature

Cedarville, OH

Aim: Probiotics are an attractive therapy for patients dealing with irritable bowel syndrome (IBS) in light of decreased financial costs, fewer medications, and a more natural approach. In this review of literature our purpose was to answer the following PICO question: “In adults with IBS, how does supplemental probiotic use compared to no probiotic use affect IBS symptoms?” Methods: In our review of the literature, the databases searched were CINAHL, MEDLINE, Cochrane, PubMed, Google Scholar, and Onesearch from the years 2008-2018; from which we found ten articles published within the last six years. Results: Seventy percent of the articles reviewed for our research identified that both the experimental (probiotic) and control (placebo) groups showed equal significant improvement in the management of IBS symptoms. Sixty percent of our articles studying multispecies versus monospecies probiotic therapy observed a greater therapeutic response when using probiotics in combination rather than individually. Lastly, 60% observed a therapeutic response in the reduction of IBS symptoms. Conclusion: The results of our review indicated that there was significant evidence for the use of probiotics in alleviating symptoms of IBS. However, the benefit of probiotics was equal to that of the placebo or not significantly greater. Therefore, we concluded that a pilot of change in practice should be considered, but there is still a need for further investigation on this topic. Keywords: Probiotics, Efficacy, Irritable Bowel Syndrome, Treatment, Management, Therapeutic, Effective.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.